Psychiatric Mental Health NP Study Guide

1. Reward and threat circuits

Reward learning helps explain why substance use can persist after pleasure fades. A substance may initially produce a rewarding effect; later, taking it to stop withdrawal also reinforces use because it removes an unpleasant state. Cues associated with use can then trigger craving before withdrawal begins. Threat learning follows a related pattern: after danger, a previously ordinary cue may evoke fear, and avoidance brings immediate relief. That relief reinforces avoidance while preventing the person from learning whether the cue is now safe. These mechanisms guide questions about triggers, relief, frequency and impairment. They cannot establish a diagnosis from behavior or a brain circuit alone. For substance concerns, assess use, withdrawal, loss of control and consequences. For fear, establish the event, current threat, symptom pattern and functional limits. SAMHSA substance use resources provide a broader care context.

Worked example: One patient drinks each morning because shaking and nausea ease afterward. Relief from withdrawal reinforces drinking; ask about quantity, attempts to stop and harms. Another stopped riding buses after a frightening collision. Avoidance quickly reduces fear but may preserve it. Ask whether danger persists, what symptoms occur on buses and how travel or work has changed.

Watch the distinction: Craving or avoidance does not identify a disorder by itself. The same behavior can arise through different pathways, so diagnosis depends on the patient's history, symptoms and impairment.

2. Attention and executive control

Attention depends on selecting relevant information, sustaining effort and shifting when circumstances change. Executive control adds planning, working memory and inhibition of an immediate response. Weak performance in either area can look like ADHD, but a symptom is not a developmental history. Establish when the difficulty began, whether it occurred across settings and how it affected school, work or relationships before the current episode. Then test competing explanations: sleep restriction reduces vigilance and response control; intoxication or withdrawal changes both; anxiety pulls attention toward perceived threats; and an elevated mood episode can increase impulsive choices. Medication timing matters because stimulants may worsen sleep or produce activation. Collateral observations help distinguish a lifelong pattern from an abrupt departure from baseline. The clinical task is to explain the change, assess immediate risk and reassess attention after reversible contributors are addressed.

Worked example: An adult who previously managed finances starts impulsive online purchases after a stimulant increase and five nights of roughly three hours' sleep. The abrupt onset does not establish lifelong ADHD. Review dose timing, other substances, mood elevation and reduced need for sleep; assess financial and safety consequences. Compare behavior with records or a close contact's account of baseline functioning.

Watch the distinction: A patient can have ADHD and still develop a separate acute problem. Attributing every impulsive act to ADHD misses medication effects, sleep loss, intoxication and mood episodes.

3. Transmitters and drug effects

Transmitters act in networks, so a drug's useful effect and adverse effects can stem from actions at the same receptor in different pathways. Dopamine signaling contributes to reward, movement and salience; dopamine blockade may reduce psychotic symptoms while impairing movement. Serotonin modulates several functions, including mood, sleep and gastrointestinal activity; drugs that increase its signaling can produce both therapeutic effects and adverse reactions. Norepinephrine influences alertness and autonomic responses. Glutamate provides much of the brain's excitatory signaling, while GABA supplies important inhibitory signaling; changing either can affect arousal, cognition and seizure risk. Receptor action, dose, timing and patient factors matter more than a slogan about a 'chemical imbalance.' When symptoms change after treatment, compare benefit with the exposure history and examination. FDA drug information is a route to product-specific safety information.

Worked example: A patient reports fewer persecutory experiences after starting a dopamine-blocking antipsychotic but develops stiffness and slowed movement. Benefit in one pathway does not rule out a drug effect in movement pathways. Document onset, dose, rigidity, tremor and functional impact; assess for urgent associated signs and revisit the treatment plan rather than calling the stiffness worsening psychosis.

Watch the distinction: Improvement in one symptom does not prove a single transmitter deficiency caused the illness. Nor does a drug's benefit make new physical symptoms unrelated to treatment.

4. Clearance, metabolites and steady state

Clearance determines how quickly the body removes active drug. With approximately linear elimination and a stable dose, each half-life closes half the remaining gap between the current concentration and its eventual steady-state concentration. About four half-lives therefore bring a drug near, but not exactly to, steady state. The same delay applies after a dose change. Renal impairment can slow removal of renally cleared compounds; hepatic impairment can alter metabolism; and active metabolites may prolong effects after the parent drug falls. Aging may change organ reserve, body composition and sensitivity. Pregnancy can change distribution and clearance in drug-specific ways, so a general dose rule is unsafe. Before interpreting a level or an apparent lack of effect, check when dosing began, adherence, sample timing, organ function and interactions. Clinical adverse effects can require action before steady state is reached.

Worked example: Assume a hypothetical drug has a 24-hour half-life, linear elimination, unchanged daily dosing and no loading dose. Four half-lives equal 96 hours, or four days. The remaining gap is (1/2)^4 = 1/16, so the concentration is about 15/16, or 93.75%, of steady state. If clearance falls, the half-life lengthens and this estimate no longer applies.

Watch the distinction: Four half-lives do not mean the drug is completely stable, and the clock resets after a meaningful dose or clearance change. Active metabolites may follow another timetable.

5. Family history and vulnerability

A family history changes the likelihood of illness before the patient's symptoms are considered; it does not supply those symptoms. Shared genes can increase vulnerability, while shared sleep patterns, stress, substance exposure and other environmental factors also contribute to family clustering. Ask which relative was affected, what episodes occurred, how the diagnosis was established and whether treatment or hospitalization clarifies the history. A vague report that someone was 'moody' carries less information than a clear account of distinct episodes with marked changes in sleep, energy and behavior. Use the history to sharpen questions and monitor for changes over time. In depression, a close relative's bipolar history makes past activation especially important to explore before altering treatment. The patient's own chronology, impairment, exposures and alternative medical explanations still drive the diagnostic formulation.

Worked example: A patient reports months of low mood and says a parent has bipolar disorder. Ask whether the patient has ever had a distinct period of increased energy, less need for sleep, rapid speech or risky decisions, including before medication use. If none is found, the family history raises vigilance but does not convert persistent low mood into bipolar depression.

Watch the distinction: Inherited vulnerability is neither destiny nor a diagnostic criterion for an individual's episode. A family label can also be inaccurate, so clarify what actually happened.

6. Sleep, circadian rhythm and stress

Sleep duration alone cannot distinguish insomnia from a mood episode. A person unable to sleep may lie awake worrying, feel exhausted the next day and wish to sleep more. Reduced need for sleep means sleeping less without the expected fatigue, often alongside a change in energy, activity, speech or judgment. Circadian timing matters as well: irregular light exposure, shift work and disrupted routines can shift sleep and wake signals, affecting alertness and mood regulation. Sustained stress increases physiological arousal and can fragment sleep, which then worsens concentration and emotional control. Ask about bedtime, actual sleep, naps, daytime fatigue, substance use and whether the pattern represents a change from baseline. In a possible manic presentation, determine the duration, associated symptoms and consequences, and obtain collateral when insight is limited.

Worked example: Both patients report four hours of sleep nightly. One spends hours worrying in bed, feels depleted and struggles to work. The other rises energetic, starts several projects and speaks much faster than usual. The second pattern raises concern for mania or another activating cause; assess course, impairment, substances and medication exposure before settling on a diagnosis.

Watch the distinction: Calling any short night a reduced need for sleep confuses an inability to sleep with an altered sleep requirement. Daytime energy and change from baseline are decisive clues.

7. Benefit and absolute risk

A treatment result needs both a definition of benefit and an absolute comparison. For a desirable outcome, subtract the usual-care event rate from the treatment event rate to obtain the absolute benefit. The reciprocal of that difference, expressed as a proportion, gives the number needed to treat, rounded up to a whole person. It estimates how many similar patients would need the added treatment for one additional person to experience the defined outcome over the study's follow-up period. Relative improvement can sound larger than the absolute gain when the baseline rate is low. Also examine the quality of the outcome: a small score change may matter less than restored work or relationships. Compare benefits with adverse effects, burden, cost and patient goals. An NNT from one population or time horizon should not be transferred uncritically to another.

Worked example: In a hypothetical study, 12 of 100 usual-care patients and 16 of 100 patients receiving added treatment meet a meaningful improvement definition. The absolute benefit is 16% minus 12% = 4 percentage points, or 0.04. NNT = 1/0.04 = 25 over that study period. One additional improvement per 25 treated must be weighed against harms and effort.

Watch the distinction: Dividing 16% by 12% gives a relative comparison, not the absolute benefit. NNT also describes an average under study conditions, not a guarantee for patient 25.

8. Association versus cause

An association describes two observations occurring together; causation requires stronger reasoning about why. In psychiatric care, treatment selection is a common confounder: patients with greater severity may receive an intensive intervention and also have a higher risk of hospitalization. The resulting association can make a helpful treatment look harmful. Selection effects can arise when the people included in a study differ from those excluded or from patients seen in practice. First identify the comparison groups and baseline differences. Then ask whether exposure preceded the outcome, whether alternative causes were measured, and whether the finding persists with a stronger design. Statistical significance addresses compatibility with chance under a model; it does not establish causation or practical importance. Translate any reported effect into absolute outcomes and ask whether its size changes decisions for a patient with similar risks and preferences.

Worked example: A chart review finds hospitalization in 18% of patients receiving a medication and 10% of others. That is an 8-percentage-point observed difference. Yet the medication group entered care with more severe symptoms and prior admissions. Those baseline differences could explain some or all of the gap; the review alone cannot show that the drug caused hospitalization.

Watch the distinction: A numerical difference is not automatically a treatment effect. Even a statistically precise association can reflect severity, treatment selection or missing data rather than causation.

9. The presenting story

A useful psychiatric interview turns a symptom label into a dated story. Start with the patient's own account of what changed and what help they want. Locate the first symptoms, their progression, discrete episodes, triggers and periods of recovery. Ask what the patient can no longer do at home, school, work or socially; severity is more than the number of symptoms. Link each prior treatment to dose or intensity, duration, adherence, benefit and adverse effects, because 'tried it' is too vague for planning. Review medical illness, medications, substances, sleep and safety alongside psychiatric symptoms. A timeline often reveals whether an apparent disorder follows an exposure, stressor or recurrent pattern. Reflect the chronology back to the patient and check discrepancies before forming a differential. Broader nurse practitioner certification study guidance can support related clinical reasoning.

Worked example: A patient says anxiety started last month. A timeline places onset just after a job loss, with new avoidance of driving to interviews. Stopping caffeine did not change it. Ask what happens while driving, whether episodes arise unexpectedly, how much work seeking is impaired and whether medication, substance use or prior episodes explain the course.

Watch the distinction: The presenting word 'anxiety' is a starting point, not a diagnosis. Skipping chronology can obscure a stress response, panic pattern, exposure effect or urgent medical symptom.

10. Mental status distinctions

The mental status examination records what the clinician observes now while clearly identifying what the patient reports. Describe appearance and behavior concretely, including engagement, activity and unusual movements. Characterize speech by rate, volume and amount. Mood is the patient's stated internal feeling; affect is the observed emotional expression, including range and congruence. Thought process describes how ideas connect, such as linear, tangential or disorganized. Thought content concerns what the patient believes or thinks about, including suspicious ideas, obsessions and self-harm thoughts. Perception addresses experiences such as hallucinations. Cognition includes attention, orientation and memory as assessed, while insight and judgment concern recognition of difficulties and decisions. These domains can diverge. Document direct quotations when wording matters, avoid interpreting a belief before exploring cultural context and degree of conviction, and note limitations when language or sensory barriers affect the examination.

Worked example: A patient says, 'I feel calm,' while crying during the interview. Speech is normal in rate and coherent; the account follows a clear sequence. The patient believes coworkers are monitoring them but reports no unusual sensory experiences. Record calm reported mood, tearful affect, organized thought process and suspicious thought content, then explore conviction and supporting evidence.

Watch the distinction: A tearful face does not make the patient's reported mood 'sad,' and an unusual belief does not itself make thought process disorganized. Record each domain separately.

11. Collateral and baseline

Collateral information is most useful when it establishes a reliable baseline and a dated change. A patient with confusion, intoxication, psychosis or cognitive impairment may be unable to describe recent function accurately; children may need developmental and school perspectives. Ask the informant what they directly observed, when it began and how it differs from usual behavior. Separate direct observations from guesses or secondhand reports, and document the source and any limits. Compare baseline independence, attention, sleep, medication use and daily tasks with the current state. Sudden loss of attention and fluctuating alertness calls for assessment of delirium and medical precipitants, even if longstanding memory problems coexist. In a gradual decline, corroborated change across months or years suggests a different investigation. Seek information in a way consistent with applicable confidentiality rules, and do not let collateral erase the patient's own perspective.

Worked example: An older adult insists memory is unchanged. A caregiver who shops with them reports independent shopping last week, then disorientation, missed meals and variable alertness over two days. That dated change points toward possible delirium rather than simply chronic cognitive decline. Assess attention and vital signs, review recent drugs and illness, and arrange urgent medical evaluation.

Watch the distinction: A caregiver's concern alone is not a diagnosis. Its value comes from specific observations and timing; a sudden change still needs examination for reversible medical causes.

12. Medication and substance review

A medication and substance review is a chronology, not just a list of names. Record when each prescription, over-the-counter product, supplement and substance was started, stopped or changed; include actual use rather than assuming the prescribed schedule. Compare that timeline with sleep, energy, perception, cognition and autonomic symptoms. Corticosteroids can be associated with activation or mood changes; stimulants can disturb sleep and increase arousal; anticholinergic burden can contribute to confusion, especially in vulnerable older adults. Alcohol and other substances can cause symptoms during intoxication or withdrawal. Temporal fit strengthens a possible causal link but does not prove it, because illness and treatment may begin together. Assess dose, competing causes, previous episodes without exposure and what happens when exposure changes. If behavior is severe, unsafe or accompanied by medical instability, address that promptly while the diagnostic investigation continues.

Worked example: A patient becomes unusually energized, sleeps little and starts costly projects four days after beginning a corticosteroid course. Establish the exact start date, dose, prior mood episodes, other substances and degree of impairment. The timing makes a medication contribution plausible, but assess for mania and immediate safety before assigning either a primary or substance-induced mood diagnosis.

Watch the distinction: A new symptom after a new drug is a clue, not proof. Conversely, ignoring timing can lead to a permanent psychiatric label for a potentially exposure-related presentation.

13. Focused medical investigation

Medical investigations should answer a question raised by the presentation. Begin with onset, vital signs, physical findings, attention, medication exposure and relevant medical history. Acute confusion with fluctuating attention suggests a systemic or neurological cause until evaluated; fever, hypoxia, dehydration, infection, metabolic disturbance and drug effects may each direct different tests. A focused test is valuable when its result can change the differential or immediate care. In a stable, longstanding anxiety presentation without new physical findings, broad testing may add incidental abnormalities while delaying a careful interview. That does not mean anxiety is always psychiatric: new chest symptoms, neurological signs or an atypical course may require medical assessment. State the suspected mechanism before ordering or interpreting a test, and compare results with the laboratory's reference interval and the patient's baseline. Reassess when new evidence changes the clinical question.

Worked example: A patient with new confusion, fever and variable attention needs prompt medical evaluation. Vital signs, examination and the suspected source guide investigations such as infection and metabolic assessment. Another patient has years of stable worry, unchanged examination and no new exposure or physical symptom. That history supports a focused psychiatric assessment rather than copying the acute confusion workup.

Watch the distinction: A standard laboratory panel cannot replace a differential diagnosis. The same result can matter greatly in acute confusion and have little explanatory value in an unrelated stable presentation.

14. Sodium and new confusion

Low serum sodium can impair brain function because a lower extracellular solute concentration allows water to shift into cells. The clinical effect depends on how low the sodium is, how quickly it fell and the patient's symptoms, so one number cannot determine safety. In a person with new confusion, review previous sodium values, fluid intake, volume status, other medicines and illnesses. Some antidepressants, including SSRIs, may contribute through inappropriate water retention, but other causes remain possible. Evaluate attention and neurological symptoms, and arrange prompt medical assessment when confusion accompanies a low result. The PMHNP's role includes recognizing the possible adverse effect, communicating medication history and coordinating further care. Do not assume psychiatric deterioration explains a new cognitive change, and do not interpret a value without its units and the laboratory's reference interval.

Worked example: A newly confused patient taking an SSRI has sodium 128 mmol/L; the case laboratory lists 135–145 mmol/L. The value is 135 − 128 = 7 mmol/L below the lower limit. Check the prior result and timing of symptoms and medication, assess neurological status and other causes, and arrange prompt medical evaluation. The arithmetic does not identify the cause or safe treatment rate.

Watch the distinction: A sodium result below range is not automatically caused by an SSRI, and its distance from the reference limit cannot by itself grade urgency. Symptoms and rate of change matter.

15. Thyroid results in context

TSH reflects pituitary signaling to the thyroid, while free thyroxine helps show the circulating hormone available to tissues. An elevated TSH may accompany reduced thyroid function, but interpretation differs when free thyroxine is low versus within the laboratory interval. Fatigue, slowed thinking and low mood can overlap with psychiatric symptoms, making symptom chronology important. Ask whether symptoms preceded the laboratory change, and review thyroid disease, relevant medicines and prior results. Lithium exposure is especially relevant because thyroid changes can emerge during treatment. An isolated TSH result neither proves that thyroid function caused depression nor excludes a concurrent depressive illness. Compare both tests with their stated reference intervals, consider repeat or additional evaluation when appropriate, and coordinate medical management while continuing to assess psychiatric severity and safety. Treatment decisions should reflect the full clinical picture rather than a single abnormal value.

Worked example: A patient with low mood has TSH 8.0 mIU/L; the laboratory interval is 0.4–4.0 mIU/L. The result is 8.0 ÷ 4.0 = 2 times the upper limit. Review free thyroxine, fatigue, cold intolerance, previous TSH values and lithium use. An in-range free thyroxine would require a different interpretation from a low value, while mood symptoms still need assessment.

Watch the distinction: An elevated TSH does not quantify how much depression is thyroid-related. Free thyroxine, symptoms, timing and treatment exposures are needed before drawing that conclusion.

16. Screens and diagnostic interviews

A screening instrument efficiently identifies symptoms that deserve closer attention; it does not establish their cause. Depression, anxiety, substance-use and cognitive screens differ in what they ask and in the populations for which results have been studied. A positive result should lead to an interview about duration, course, impairment, context and safety. A negative result also needs judgment when the patient reports significant difficulty or cannot complete the instrument reliably. In depression assessment, ask about prior activation before selecting treatment. In cognitive assessment, consider language, education, sensory barriers and acute illness, which can affect performance. Track a repeated score alongside functioning and adverse effects, rather than treating a small score change as recovery. Explain to the patient what the screen indicates and what remains uncertain. NIMH mental health information offers general context on disorders and treatment.

Worked example: A patient recently bereaved screens positive for depression. Explore the time course, pervasive versus wave-like low mood, loss of function, suicidal thoughts, sleep, substance use and any past periods of activation. The screen warrants assessment but cannot distinguish grief, a depressive episode or another cause. Treatment follows the resulting formulation and the patient's priorities.

Watch the distinction: A score above a tool's cutoff is not a diagnosis. It can prompt needed questions, but symptom context and risk assessment determine what the PMHNP does next.

17. Unipolar or bipolar depression

Depression can occur in both unipolar and bipolar illness, so the current low mood alone cannot separate them. Search for distinct past periods of increased energy or activity, reduced need for sleep, unusually rapid speech, inflated confidence, risky choices and a clear change from baseline. Establish duration, impairment and whether symptoms occurred before antidepressants or stimulants. Antidepressant-associated activation warrants careful review, but medication exposure complicates attribution rather than settling the diagnosis. Family history raises suspicion without proving the patient's illness. Ask about episode spacing and periods of ordinary functioning, and obtain collateral if memory or insight is limited. This distinction affects treatment planning because a history of mania or hypomania changes how antidepressant treatment is evaluated. Assess current safety, psychosis and functional consequences while the longitudinal history is clarified.

Worked example: A depressed patient recalls several days of little sleep, fast speech and spending far beyond their means before ever receiving an antidepressant. Clarify whether they felt rested, how different the behavior was, whether others noticed and what consequences followed. That earlier episode raises bipolar concern; investigate it before simply increasing the antidepressant, while addressing current depressive risk.

Watch the distinction: A brief improvement in mood or ordinary productivity is not hypomania. Look for an episode with a sustained change in energy, associated symptoms and a meaningful shift from baseline.

18. Mania, anxiety and ADHD

The key distinction is course. ADHD-related distractibility and impulsivity generally trace back to development and appear across relevant settings, although demands can expose previously compensated difficulties. Mania involves an episodic departure from baseline with altered mood and energy; reduced need for sleep, increased goal-directed activity and consequential decisions strengthen that possibility. Anxiety can cause restless concentration and poor sleep, but patients often feel tired and remain focused on threat or worry. Stimulant exposure and other substances may produce activation or worsen sleep, so establish dose and timing. Ask what the person was like before the change, whether symptoms persist when rested, and how behavior affects work, finances and relationships. A patient may have longstanding ADHD plus a new mood or exposure-related episode. The PMHNP should assess immediate impairment and safety while gathering a longitudinal history.

Worked example: An adult has been distractible since school but develops a week of expansive mood, very little sleep and major purchases. Lifelong attention difficulty does not explain this new pattern. Ask whether they feel rested, whether speech and activity changed, and whether stimulants or other substances preceded it. Assess financial harm and possible mania while confirming the older ADHD history.

Watch the distinction: A longstanding ADHD label does not explain every later burst of energy or spending. New episodic symptoms require a fresh mood, sleep and exposure assessment.

19. Psychosis over time

Psychosis is best formulated on a timeline that places hallucinations or delusions alongside mood episodes, substance exposure and medical illness. If psychotic symptoms occur only during a severe depressive or manic episode, a mood disorder with psychotic features becomes an important consideration. Psychosis that clearly persists during prolonged periods without a mood episode points toward another primary psychotic formulation, though the full course and diagnostic criteria still matter. Substance-induced symptoms require attention to intoxication, withdrawal and persistence after exposure changes. Sudden onset with fluctuating attention or neurological findings raises medical concerns. Ask about the patient's exact experiences, degree of conviction, distress and functional effect, while considering cultural meaning. Collateral, records and repeated assessment often resolve uncertain chronology better than a single interview. Immediate safety and ability to care for basic needs remain part of the assessment.

Worked example: Patient A hears accusatory voices only during clearly severe depressive episodes; the voices stop when mood recovers. Patient B reports similar voices through several months of stable mood. A mood-linked psychotic presentation fits A's timeline more closely; B needs evaluation for a primary psychotic disorder and other causes. For both, check substances, medical changes, risk and corroborating history.

Watch the distinction: The content of a hallucination alone rarely identifies its cause. Its timing relative to mood, substances and cognition is usually more informative than whether the voice sounds depressive.

20. Delirium and cognitive decline

Delirium is an acute disturbance in attention and awareness that often fluctuates over hours or days. A person may alternate between alertness and drowsiness, struggle to follow a conversation and show disorientation or perceptual changes. Major neurocognitive disorder more often involves a sustained decline from prior functioning over a longer course, though it can increase vulnerability to delirium. Depression can impair concentration and memory, but a sudden fluctuating inability to sustain attention needs medical assessment. Establish the last known baseline through collateral, examine attention and vital signs, and review illness, dehydration, medications and substance withdrawal. Avoid assuming that a patient with known cognitive impairment is simply showing their usual symptoms. The immediate decision is whether acute medical evaluation is needed; detailed classification of longer-term cognition can follow once the acute state is addressed.

Worked example: An older adult paid bills independently last week but now drifts between alertness and drowsiness and cannot follow a short conversation. The abrupt decline and fluctuating inattention make delirium a priority. Obtain vital signs and a medication and illness history, seek collateral about the last normal day, and arrange urgent medical evaluation before interpreting chronic memory function.

Watch the distinction: Disorientation in an older adult is not automatically dementia. A rapid change in attention or alertness can signal delirium, including when underlying cognitive decline is already present.

21. Panic and medical mimics

A panic attack is a sudden surge of intense fear or discomfort with physical symptoms such as palpitations, breathlessness, sweating, and trembling. Panic disorder requires more than an attack: ask whether attacks recur unexpectedly and whether fear of another attack or related avoidance persists. Generalized anxiety usually involves sustained worry across several areas of life, although it can coexist with panic attacks. Reconstruct onset, duration, triggers, substance use, medications, and the patient's interpretation of the symptoms. Caffeine, stimulants, and withdrawal can produce similar sensations. New chest pressure, fainting, marked breathlessness, or an abnormal examination calls for medical assessment before a psychiatric explanation is accepted. A familiar pattern may guide the differential, but it does not make a new or unusually severe episode medically harmless.

Worked example: A patient with no panic history develops chest pressure, sweating, and shortness of breath while walking upstairs. The exertional onset and first occurrence make an acute cardiopulmonary cause a priority, so arrange immediate medical assessment. After medical evaluation, ask whether there have been other sudden attacks, persistent fear of recurrence, avoidance, or substance exposure before considering a panic diagnosis.

Watch the distinction: Labeling chest symptoms as panic because the patient looks frightened reverses the reasoning. Fear can follow a medical event, and a first attack still needs assessment for urgent causes.

22. Obsessions and repeated behavior

An obsession is a recurring, intrusive thought, image, or urge that the person usually experiences as unwanted. A compulsion is a repeated act or mental ritual performed to reduce distress or prevent a feared outcome, even when the connection is unrealistic or excessive. Ask what happens if the behavior is delayed: rising anxiety followed by relief after the ritual supports this pattern. Insight varies, so limited insight alone does not settle the diagnosis. A delusion is a fixed belief held with strong conviction despite contrary evidence; generalized worry concerns plausible problems across life domains without a stereotyped ritual. Repetitive behavior in autism may provide sensory comfort or predictability rather than neutralize an intrusive fear. Assess time consumed, impairment, avoidance, and whether the person can describe the thought as their own.

Worked example: A patient fears that touching a door handle will contaminate their family, calls the fear excessive, and washes until anxiety briefly falls. The intrusive fear and relief-producing ritual suggest an obsession and compulsion. Another patient firmly believes a neighbor is poisoning the water and avoids it without intrusive doubt or a washing ritual; assess that belief within a psychosis differential.

Watch the distinction: Assuming every repeated act is a compulsion misses its function. Ask whether the act neutralizes an unwanted fear, serves a sensory need, follows a fixed belief, or reflects ordinary habit.

23. Trauma, grief and adjustment

Begin with the event and the pattern that followed it. Trauma-related illness involves exposure to a qualifying traumatic event and may include intrusive re-experiencing, avoidance, changes in mood or beliefs, and heightened arousal. Timing, duration, distress, and impairment matter; an immediate reaction and a persistent syndrome require different formulations. An adjustment reaction follows an identifiable stressor but need not involve traumatic exposure or trauma-specific symptoms. Bereavement may bring waves of sadness, yearning, and reminders of the deceased without automatically indicating a disorder. Examine whether symptoms are tied to memories of danger, a life change, or loss, while asking about safety, functioning, and prior illness. In children, play, behavior, or separation concerns may express distress differently from an adult's account. Mental health topics provide broader disorder context.

Worked example: After an assault, a patient has unwanted sensory memories, avoids the street where it happened, and startles at footsteps. That trauma-linked pattern warrants a trauma assessment. Distress after a nontraumatic move may fit an adjustment formulation if it impairs functioning. Yearning after a death calls for a grief history, including its course and any additional depressive symptoms.

Watch the distinction: Treating every painful event as trauma, or every grief reaction as illness, obscures the defining exposure and symptom pattern. Distress deserves care even when a specific trauma diagnosis does not fit.

Reference: [2]

24. Developmental and complex presentations

A developmental diagnosis rests on a pattern across time and settings, not a single difficult week. For ADHD, ask about earlier attention and impulse-control difficulties, school and home functioning, and competing causes such as sleep loss, anxiety, trauma, or substances. Autism-related concerns require a developmental account of social communication and restricted or repetitive patterns, interpreted in cultural context. Eating pathology may appear at any body size; restriction, purging, fainting, and medical signs can outrank a diagnostic interview in urgency. Recurrent relationship difficulties, dissociation, and somatic distress also need a longitudinal account before assigning a label during crisis. Clarify what preceded what, obtain appropriate collateral, and address immediate safety first. Cases in the PMHNP study guide can help rehearse these competing explanations.

Worked example: A teenager reports poor concentration that began after months of short sleep. They also disclose restrictive eating and two fainting episodes. Assess current medical stability promptly, including vital signs and relevant examination, while evaluating eating behavior and sleep. Review childhood records and observations across settings later; the recent inattention alone does not establish ADHD.

Watch the distinction: A normal-looking body size does not exclude dangerous eating pathology. Likewise, recent inattention should not be called ADHD before sleep, nutrition, trauma, and the earlier developmental course are examined.

25. Choosing an antidepressant

Antidepressant selection begins by confirming the target syndrome and asking about previous periods of elevated or irritable mood, reduced need for sleep, and increased activity. Those features may change the treatment strategy. A prior useful response is informative only when dose, duration, adherence, and reason for stopping are known. Then compare options against the patient's comorbidities, other medicines, interaction potential, adverse effects, and preferences. Sexual effects, sleep changes, gastrointestinal symptoms, and discontinuation difficulties may matter more to one patient than another. Agree on a functional target and a follow-up plan that checks symptoms, activation, tolerability, and adherence. If benefit is incomplete, first establish actual exposure and remaining impairment before switching or adding treatment. Drug safety information can support product-specific review.

Worked example: A patient says a previous antidepressant lifted mood but they stopped it because sexual adverse effects strained a relationship. Clarify how long they took it, the dose, and whether function improved. Ask about past activation and current medicines, then compare a retrial with alternatives that may better fit their priorities. Document the chosen target, adverse effects to watch, and reassessment plan.

Watch the distinction: Repeating a previously helpful drug without asking why it was stopped may reproduce the problem that ended treatment. A history of possible mania also needs evaluation before an antidepressant change.

Reference: [4]

26. Lithium monitoring

Lithium is cleared mainly through the kidneys, so changes in renal function, hydration, sodium balance, or interacting medicines can raise exposure. Vomiting, diarrhea, fever, or reduced intake may alter fluid balance while also making toxicity harder to recognize. Ask about new tremor, unsteady gait, confusion, and gastrointestinal symptoms, then assess urgency from the current presentation rather than an old laboratory result. Monitoring joins correctly timed serum sampling with kidney function, thyroid function, clinical effects, and medicine reconciliation. The time of the last dose and blood draw matters because a level taken at an unexpected point after dosing can mislead interpretation. A single concentration is one part of assessment; symptoms and changing clearance can require prompt evaluation even when an earlier level was reassuring.

Worked example: A patient taking lithium develops vomiting, coarse tremor, and unsteady walking after dehydration and a new interacting medicine. A level from last month describes neither today's exposure nor today's renal function. Arrange urgent medical assessment, identify the new medicine and last lithium dose, and obtain current clinical and laboratory evaluation. Record the sampling time when interpreting the new level.

Watch the distinction: A previously acceptable lithium level is not a safety guarantee. Fluid loss, renal changes, and interacting drugs can alter exposure quickly, while an incorrectly timed sample may confuse the result.

Reference: [4]

27. Comparing mood stabilizers

Mood stabilizers differ in mechanism, adverse effects, interactions, and suitability for particular phases of illness. Compare the symptom target and prior response before weighing patient-specific constraints. Lithium calls for attention to renal and thyroid effects; valproate raises reproductive, hepatic, and blood-count concerns; carbamazepine has substantial interaction and blood-count considerations; lamotrigine requires careful attention to rash and gradual titration. These are distinct risk profiles, not interchangeable labels. Pregnancy planning should prompt a discussion of fetal exposure, untreated illness, and the patient's priorities with coordinated obstetric care. Existing liver disease or cytopenias may narrow options, while a serious prior drug rash changes the safety assessment. Review current medicines for interactions, define what will be monitored, and revisit the choice if the illness phase or reproductive plans change.

Worked example: A patient planning pregnancy has chronic liver disease and previously developed a serious rash while taking lamotrigine. Valproate presents reproductive and hepatic concerns; restarting lamotrigine could be unsafe given the rash history. Review the exact reaction, illness course, renal status, past benefit, and pregnancy goals before considering other options with coordinated psychiatric and obstetric input.

Watch the distinction: Choosing a mood stabilizer by category alone overlooks major differences. The phase of illness, pregnancy plans, organ function, prior rash, and interacting medicines can change which option is reasonable.

Reference: [4]

28. Antipsychotic tradeoffs

An antipsychotic decision balances expected symptom benefit against risks the patient already carries. Review previous efficacy, dose, adherence, and why treatment stopped. Dopamine blockade can produce stiffness, tremor, or akathisia; other effects vary across agents and include weight gain, glucose or lipid changes, sedation, prolactin effects, and cardiovascular concerns. A patient with diabetes needs a plan for metabolic measures and coordination of physical health care. A patient with prior movement symptoms needs a detailed description of timing and severity, since akathisia can look like agitation and lead to an unhelpful dose increase. Consider the patient's priorities, routes of administration, and capacity to follow monitoring. Reassess both psychiatric functioning and adverse effects after a change, because improvement in one does not erase harm in another.

Worked example: A patient with diabetes recalls that an earlier antipsychotic reduced hallucinations but caused severe stiffness. Clarify the drug, dose, onset of stiffness, and whether it resolved after a change. Compare options using prior benefit and movement and metabolic risks, then agree on symptom goals and monitoring of weight, glucose-related measures, and movement findings.

Watch the distinction: The most effective past treatment is not automatically the best next choice if its adverse effects were severe. Equally, diabetes alone does not settle the decision without comparing benefit and monitoring needs.

Reference: [4]

29. Akathisia and clozapine alerts

Akathisia is a medication-related sense of inner restlessness often accompanied by pacing or inability to sit still. Ask the patient what the movement feels like and relate its onset to an antipsychotic start or dose increase. It can be mistaken for worsening anxiety, psychosis, or behavioral agitation; increasing the same drug may intensify the problem. Clozapine requires a different alertness to serious adverse effects. Severe constipation with abdominal pain or vomiting may signal dangerous bowel slowing, while fever or other infection symptoms, chest symptoms, and blood-count abnormalities need prompt assessment under applicable monitoring requirements. Establish symptom onset, severity, current medicines, and red flags, then act on the medical risk. Do not wait for a routine psychiatric follow-up when a potentially serious physical complication is present.

Worked example: A patient begins pacing two days after an antipsychotic dose increase and describes an unbearable need to move. Assess for akathisia before calling it relapse. Separately, a patient taking clozapine reports several days without a bowel movement and worsening abdominal pain. Arrange prompt medical evaluation for possible serious gastrointestinal hypomotility rather than offering only routine constipation advice.

Watch the distinction: Pacing is not proof of worsening psychosis, and clozapine constipation is not always minor. Timing, the patient's inner experience, and associated medical symptoms determine the safer response.

Reference: [4]

30. ADHD medication follow-up

ADHD medication follow-up measures useful change in daily function alongside adverse effects. Ask what improved at school, work, and home rather than relying only on a concentration rating. Stimulants can worsen sleep or appetite and may raise concerns when cardiovascular symptoms, relevant history, or misuse risk are present. Nonstimulant options have different onset and adverse-effect profiles, so the best choice depends on the person's goals and constraints. For children, track growth over time and gather observations from caregivers and school with appropriate consent. Check when doses are taken, whether benefit covers the needed part of the day, and whether rebound symptoms or insomnia follow. If attention improves while eating, sleep, or mood deteriorates, adjust the plan rather than treating the symptom score as the sole outcome.

Worked example: A student completes more assignments after starting a stimulant, but now skips lunch and lies awake late. Confirm dosing time, actual food intake, sleep pattern, and classroom benefit. Discuss a dose or timing change or another treatment, then reassess both completed work and physical effects. For a child, add serial growth observations to the follow-up.

Watch the distinction: Improved concentration does not by itself mean treatment is successful. Sleep loss, poor intake, cardiovascular symptoms, or misuse can outweigh the benefit and require a revised plan.

Reference: [4]

31. Sedatives and interactions

Benzodiazepines and opioids can each suppress alertness and breathing, so their combined effects increase risk, especially in a frail older adult or with alcohol. Assess falls, daytime sedation, dose history, alcohol use, and why each medicine was prescribed. Physiologic dependence can develop; an abrupt benzodiazepine stop after sustained use may cause dangerous withdrawal, so reduction must be individualized and monitored. Interaction reasoning also needs a mechanism. CYP inhibitors may raise a drug's exposure, while inducers may lower it; changes in tobacco smoking can alter metabolism of certain medicines. Combining serotonergic drugs raises toxicity concern, and several QT-prolonging factors can accumulate. The response depends on the specific agents, dose, patient vulnerabilities, symptoms, and whether a safer alternative or closer monitoring is available.

Worked example: An older adult taking a nightly benzodiazepine starts an opioid for pain and then falls twice. Review sedation, breathing symptoms, alcohol use, and the timing of both medicines; coordinate an immediate safety review. If the benzodiazepine has been used regularly for months, plan a monitored, individualized reduction rather than stopping it suddenly. Address the opioid regimen and fall hazards as well.

Watch the distinction: Treating every interaction as an automatic reason to stop both drugs misses withdrawal and pain needs. Conversely, calling two sedating prescriptions routine ignores their combined effects and new falls.

Reference: [4]

32. Medication toxicity patterns

Medication toxicity is recognized by linking exposure and timing to examination findings. Serotonin toxicity often follows a serotonergic addition or dose change and features neuromuscular overactivity such as hyperreflexia or clonus with autonomic and mental-status changes. Neuroleptic malignant syndrome follows dopamine blockade or related changes and tends toward marked rigidity, fever, and altered consciousness. Anticholinergic toxicity may cause dry skin, dilated pupils, urinary retention, and confusion. Withdrawal requires a history of reduced or stopped exposure; its signs depend on the substance. These patterns overlap and can be medically dangerous, so check vital signs, temperature, muscle findings, hydration, and the full medicine and substance timeline. Stop a suspected offending exposure within an urgent medical response rather than waiting for a complete diagnostic label before escalation.

Worked example: After adding a second serotonergic medicine, a patient becomes agitated and sweaty with tremor and hyperreflexia. The exposure and neuromuscular findings favor serotonin toxicity and require urgent medical assessment. If the patient instead developed marked rigidity after a dopamine-blocking drug, consider neuroleptic malignant syndrome. Dry skin and urinary retention would shift attention toward anticholinergic toxicity.

Watch the distinction: Fever and agitation alone do not identify the syndrome. Medication timing and neuromuscular findings help separate causes, while any severe presentation warrants prompt medical care.

Reference: [4]

33. Cognitive behavioral formulation

A cognitive behavioral formulation follows a sequence: situation, interpretation, emotion, physical response, and action. The interpretation is a testable account of what the event means, not an objective fact. Avoidance or withdrawal can then reduce opportunities for reward and leave the interpretation unchallenged, maintaining distress. Ask for a recent specific event, the exact thought, its felt credibility, and what the person did next. A cognitive intervention examines evidence and plausible alternatives; a behavioral intervention tests a prediction in real life. Choose a task small enough to be completed and measure what happens, including mood and function. This approach also reveals when an apparently distorted thought reflects a real danger or practical problem that needs support rather than mere reframing.

Worked example: After missing one call, a patient thinks, “I always fail,” feels hopeless, and stays in bed. Ask for evidence for and against “always,” then form the more precise thought, “I missed one call and can return it.” Agree on returning the call and taking a short walk. At follow-up, compare predicted rejection and actual response, mood, and activity.

Watch the distinction: Telling someone to think positively skips the evidence and behavior sustaining distress. A useful intervention tests a specific interpretation and observes what changes when the person acts differently.

34. Behavioral activation

Depression often reduces activity before motivation returns. Withdrawal removes social contact, mastery, and pleasure, which can deepen low mood and make further activity seem harder. Behavioral activation interrupts that cycle by choosing small actions linked to the patient's values, scheduling them, and reviewing what actually happened. Begin with a baseline of activities and mood, then identify avoidance and practical obstacles such as transport, fatigue, or caregiving. Pick a task that is feasible even with low energy and define when, where, and with whom it will occur. Record anticipated difficulty and the observed effect on mood or function. The goal is increased engagement, not a promise that every activity will feel good. Adjust the plan if the task was too large or the predicted obstacle proved real.

Worked example: A patient has stopped seeing friends because they expect a walk to feel unbearable. They agree to walk with one friend for ten minutes on Saturday and rate expected difficulty as 9 out of 10. Afterward, they rate actual difficulty 5 out of 10 and report feeling less isolated. Use that difference to plan the next manageable activity.

Watch the distinction: Waiting for motivation before scheduling activity can prolong withdrawal. Activation asks for a small, meaningful action first, then uses the observed result to refine the plan.

35. Exposure and response prevention

Exposure works by approaching a feared cue in a planned, manageable way while reducing the avoidance or ritual that keeps fear untested. In obsessive-compulsive symptoms, response prevention means resisting the compulsion after the cue appears. Repeated checking may lower distress briefly, but that relief teaches the person to rely on checking again. Build a hierarchy with the patient, agree on a step they can attempt, and distinguish ordinary safety behavior from excessive ritual. During practice, observe distress and the urge to seek reassurance without making immediate relief the only measure of success. Repetition can help the person learn that uncertainty is tolerable and the feared outcome does not need a ritualized response. Work collaboratively, assess readiness, and avoid forcing an exposure that the patient cannot understand or safely attempt.

Worked example: A patient checks the stove eight times before leaving. After confirming ordinary stove safety, they agree to check once, leave for a short walk, and resist returning to check again. They record distress rising and then falling while away. At review, discuss whether the feared fire occurred, how long the urge lasted, and whether the step needs repeating before advancing.

Watch the distinction: Repeated reassurance or a final extra check may feel supportive but can strengthen the ritual cycle. Exposure requires a clear safety boundary and practice tolerating the remaining uncertainty.

36. Dialectical behavior skills

Dialectical behavior therapy organizes treatment by priority. Immediate life-threatening behavior and current safety come first, followed by behavior that disrupts treatment and then problems that impair quality of life. A chain analysis traces vulnerability factors, prompting event, thoughts, emotions, body sensations, actions, and consequences. This shows where a skill might interrupt the sequence. Distress tolerance helps a person survive an intense moment without making it worse; emotion regulation addresses patterns that increase vulnerability; interpersonal skills support clear requests and limits. Validation acknowledges the person's experience while still working toward change. After any self-injury, assess injury, intent, ongoing danger, and available support before using the event as a skills exercise. The selected skill should match the point in the chain where the person could realistically use it.

Worked example: After self-injury during an argument, assess wounds, suicidal intent, and immediate safety. Once safe, map the chain: poor sleep, criticism, shame, rising tension, then self-injury followed by brief relief. Rehearse a distress-tolerance action for the tension point and a direct request for a pause in future arguments. Review whether either step can be used with available supports.

Watch the distinction: Starting with communication coaching while injury or suicidal intent remains unassessed gets the priorities wrong. Skills work follows immediate safety assessment and a careful account of the behavior chain.

37. Motivational interviewing

Motivational interviewing explores ambivalence without arguing the patient into change. Ask open questions, reflect both the perceived benefit of a behavior and its costs, and listen for the patient's own reasons, ability, and wish to change. A person who drinks to sleep may also dislike missed work; both statements matter. Summaries can connect the discrepancy between current behavior and a valued goal without shaming. Ask permission before offering information and check how the patient interprets it. A useful next step is specific, achievable, and chosen by the patient, with a plan to review what happened. If the person is not ready to reduce use, discussion of immediate safety and support remains useful. Substance use resources can supplement a collaborative care plan.

Worked example: A patient says alcohol calms them at night but they have missed two work shifts this month. Reflect: “It helps you settle, and missing work worries you.” Ask which change feels possible. They choose to record drinking and sleep for one week and call a support person before the next workday. At follow-up, review the record without treating a setback as failure.

Watch the distinction: Listing harms until the patient agrees may increase defensiveness. Change talk is more useful when it comes from the patient's values and leads to a step they chose.

Reference: [3]

38. Interpersonal and supportive work

Match psychotherapy to the problem the patient wants to change and the capacity available now. Interpersonal work focuses on relationships and current roles, including grief, disputes, transitions, and isolation that connect with mood symptoms. Supportive work strengthens coping, practical problem solving, and the therapeutic relationship when immediate stability is central. Exploratory or psychodynamic work examines recurring emotional and relational patterns when the patient wants that depth and can reflect on them without losing current safety or functioning. These approaches can overlap, but the initial focus should be explicit. Ask what changed around symptom onset, what happens between people, and what the patient hopes treatment will accomplish. Revisit the formulation if crises, cognitive limitations, or new information make the original approach a poor fit.

Worked example: Depression worsens after a promotion changes a patient's role at home and triggers conflict with a partner. If they want to address that transition, interpersonal work can map expectations and practice a conversation. If the patient is overwhelmed by an immediate housing problem, supportive sessions may first organize coping and resources. Deeper recurring patterns can be explored when the patient is ready.

Watch the distinction: Choosing a therapy solely by diagnosis overlooks the patient's central problem and current capacity. A sound match names the target, the work required, and how progress will be recognized.

39. Family and trauma-focused care

Caregiver involvement should fit the young person's developmental stage, preferences, and safety needs. Caregivers can support routines, coping practice, and access to treatment, while the clinician still builds a direct alliance with the adolescent. Trauma-focused work can help when the person is ready to engage with traumatic memories, but acute danger, severe dissociation, or unstable substance use may make intensive processing hard to tolerate or unsafe to sustain. Assess triggers, grounding ability, current supports, and what happens during recounting. Stabilization can include safety planning, emotion regulation, predictable sessions, and coordinated treatment of substance-related problems. Explain the purpose of each step and invite meaningful choice. Reassess readiness over time so preparation does not become indefinite avoidance of effective trauma-focused care.

Worked example: An adolescent asks for trauma treatment but becomes disoriented and loses track of the room when describing the event. Pause detailed recounting, assess current safety, and practice grounding that restores orientation. With appropriate consent, enlist a caregiver to support sleep and coping between visits. Revisit trauma processing once the adolescent can remain present and has a workable plan for distress.

Watch the distinction: Pushing through dissociation can undermine engagement and safety. Yet preparation should have clear goals and review points so it does not become a permanent reason to avoid trauma treatment.

40. Suicide risk formulation

A suicide screen identifies a need for deeper assessment; it cannot determine risk or disposition alone. Ask directly about current thoughts, intent, a specific plan, access to means, preparation, past attempts, and changes in intensity. Explore acute stressors, intoxication, agitation, hopelessness, psychiatric symptoms, and the person's ability to use support. Protective factors matter when they are accessible and credible in the current crisis, but they do not cancel imminent intent or ready means. Formulate risk as a time-sensitive judgment: what might happen soon, what could interrupt it, and what level of supervision or emergency care is needed now. Document the reasoning, actions to reduce access to means, people involved, and the reassessment plan. Risk can change rapidly, so a reassuring earlier interview does not settle a new presentation.

Worked example: Two patients endorse suicidal thoughts on the same screen. One has a specific plan, immediate access to the means, and says they intend to act tonight; arrange immediate protective evaluation and address access. The other denies intent or preparation, wants family support, and can participate in a safety plan. Assess further and arrange a level of care and follow-up matched to that fuller picture.

Watch the distinction: Identical screen results do not imply identical risk. Plan, intent, means, prior behavior, current stressors, and usable support determine the immediate response, which must be reassessed as circumstances change.

Reference: [3]

41. Collaborative safety planning

A safety plan is a sequence the patient can use as distress rises. Start with personally recognizable warning signs, such as withdrawing from friends or rehearsing self-harm. Agree on coping steps the patient can try alone, then name people and places that offer distraction, people who can provide direct help, and crisis services for moments when those steps fail. Record names, contact methods, and a backup if someone is unavailable. Means safety requires a concrete change in access, developed with the patient and, when appropriate, a trusted supporter. Ask the patient to describe how they would use the plan and identify obstacles such as a dead phone or reluctance to call. Reassess current intent and access throughout; a written plan cannot replace emergency care when immediate safety cannot be maintained.

Worked example: A patient identifies staying alone after work as an early warning sign. They agree to walk to a nearby café, then call a named sibling if thoughts intensify. With consent, the sibling will hold the patient's stored medication; the patient records a crisis contact as the next step. Asked to rehearse the plan, the patient explains where the numbers are saved and what they will do if the sibling does not answer.

Watch the distinction: A promise not to self-harm is not a safety plan. It gives neither usable steps nor a way to reduce access to means when distress rises.

Reference: [3]

42. Threats toward others

Assess a threat as a developing situation, not as a property of a diagnosis. Ask what was said, who is involved, whether the patient intends harm, and whether a plan, time, place, or preparatory act exists. Determine access to weapons and whether the patient has approached the target, made repeated threats, or become more agitated. Intoxication, persecutory beliefs, recent losses, and prior violence may affect the formulation; reasons for restraint and willingness to accept help also matter. Seek collateral information when appropriate and document the patient's exact statements and your assessment. Immediate safety measures and consultation may be needed while facts are clarified. Duties to warn, protect, report, or disclose vary by jurisdiction, so a case must state the applicable rule before a particular legal action can be selected.

Worked example: A patient says a coworker 'will pay' and reports a firearm at home. The PMHNP asks whether the coworker is the intended target, whether the patient has decided to act, and whether a date or approach has been planned. If the case states that an identifiable target and credible imminent threat trigger protective disclosure, those established facts guide the required action. Access alone warrants safety assessment but does not establish intent.

Watch the distinction: Anger plus a psychiatric diagnosis does not prove imminent violence. Equally, a calm interview does not erase a specific plan and ready access to a weapon.

43. Agitation and hidden illness

Sudden agitation can be a sign of physiologic distress. Create space, reduce noise and crowding, speak calmly in short sentences, and offer simple choices while maintaining an exit and help nearby. At the same time, assess onset, orientation, attention, vital signs, oxygenation, pain, recent medication changes, and possible intoxication or withdrawal. Fluctuating attention and disorientation suggest delirium; rapid breathing or low oxygen may indicate an urgent cardiopulmonary problem. Sedating an unexplained presentation can obscure deterioration and may worsen some medical conditions. The sequence is to protect everyone, look for reversible causes, treat or escalate medical instability, and reassess behavior after those causes are addressed. If medication or a more restrictive intervention is needed for immediate safety, continue monitoring and document the clinical reason.

Worked example: An inpatient who was conversing normally an hour ago begins shouting, cannot state where they are, and breathes rapidly. Staff lower stimulation and maintain distance while obtaining vital signs and urgent medical assessment, including oxygenation. Acute onset plus impaired orientation makes a simple psychiatric relapse insufficient as an explanation. The PMHNP communicates the change from baseline and reassesses once the medical problem is evaluated.

Watch the distinction: Calling all agitation 'behavioral' can delay treatment of hypoxia, pain, delirium, or intoxication. De-escalation and medical assessment should proceed together when the change is abrupt.

44. Withdrawal and overdose

Different substance emergencies call for different immediate responses. Opioid toxicity commonly suppresses breathing and consciousness; activate emergency help, support airway and breathing, and use an available opioid reversal medication within the care setting's procedures. Continue observation because breathing can worsen again after reversal. Alcohol or sedative withdrawal follows reduction or cessation after sustained exposure and may progress from tremor, sweating, and anxiety to confusion, seizures, or marked autonomic instability. Severe intoxication can also impair breathing, temperature regulation, or decision-making. Establish what substance was used, amount when known, last use, co-ingestants, and the time course, but do not let history taking delay resuscitation. A PMHNP should recognize the pattern, initiate appropriate emergency measures, and coordinate medical treatment before routine psychiatric evaluation.

Worked example: A person found after suspected opioid use is difficult to wake and breathes slowly. The immediate priority is emergency response, breathing support, and an available reversal medication, followed by observation. A second person stopped heavy daily drinking and now has tremor, confusion, and sweating. That pattern suggests potentially severe withdrawal and requires urgent medical assessment rather than a standard anxiety visit.

Watch the distinction: Improved alertness after opioid reversal does not guarantee sustained recovery. Likewise, tremor after stopping alcohol is not automatically harmless anxiety; withdrawal can escalate.

Reference: [3]

45. Choosing a level of care

Choose a setting by asking what care and supervision are needed now. First assess medical stability, intoxication, delirium, and the patient's ability to participate in decisions. Then evaluate suicidal or violent intent, plans, access to means, recent behavior, and the speed at which risk may change. Protective factors matter only if they are available and usable. Outpatient care requires a workable safety plan, reliable follow-up, and sufficient support; more intensive community care can bridge some gaps. Imminent danger, inability to maintain safety, or urgent medical needs may require emergency evaluation or inpatient care. The least restrictive feasible setting is the one that can actually meet the person's needs, not simply the setting with the fewest limits. Involuntary intervention depends on the jurisdictional criteria supplied in a case.

Worked example: One patient reports passive thoughts, denies intent, engages in means safety, has a reachable supporter, and can attend prompt follow-up. Outpatient management may be feasible if the full assessment supports it. Another has current intent, an accessible method, and no safe supervision. Emergency evaluation is warranted because a plan and appointment cannot control that immediate risk.

Watch the distinction: The least restrictive option is not automatically outpatient care. Restrictions are justified by the specific safety and treatment needs that a less intensive setting cannot meet.

46. Emergency intervention sequence

In a crisis, sequence decisions so uncertainty does not delay protection. Establish immediate safety, summon help, and reduce access to hazards. Assess airway, breathing, vital signs, intoxication, injury, and other medical causes of altered behavior. Use calm communication and the least restrictive effective measures while the patient is unable to participate fully. Once medically stable and sufficiently alert, repeat the psychiatric risk assessment; intoxicated statements remain important, but a reliable disposition requires reassessment. Document the initial behavior, medical findings, interventions, response, collateral information, and reason for the chosen setting. If a scenario supplies a local emergency hold rule, apply its actual criteria to the observed facts and record that reasoning. Without such facts, do not assume that intoxication alone authorizes detention.

Worked example: An intoxicated patient says they will die tonight but cannot answer questions coherently. Staff remove immediate hazards, arrange urgent medical evaluation, and maintain observation. After the patient becomes able to engage, the PMHNP reassesses intent, plan, means, and supports. If the stated local rule permits an emergency hold for imminent danger, the documented findings determine whether it applies.

Watch the distinction: A later denial does not make the original threat disappear. Reassessment should integrate both accounts, the intoxication timeline, access to means, and collateral information.

47. Shared goals and follow-up

A shared plan connects the patient's priorities to observable changes. Identify the most urgent problem first, then ask what improved functioning would look like in daily life. Set a specific goal, establish a baseline, agree on a treatment choice, and decide how progress and adverse effects will be measured. Symptom scales can help track change, but attendance, relationships, sleep, and safety may matter more to the patient. Explain expected benefits and burdens in plain language and invite the patient to choose among reasonable options. Follow-up timing should reflect current risk, treatment changes, tolerability, and available support. State what should trigger earlier contact and who is responsible for each action. Revisit the plan when the patient's goals or circumstances change rather than treating the first plan as fixed.

Worked example: A student with depression says returning to class matters most. They currently attend none of their three weekly seminars. The agreed goal is to attend one seminar each week for the next two weeks while beginning a chosen treatment and tracking sleep and adverse effects. At review, attendance rises from zero to one seminar weekly, showing functional progress, though remaining symptoms still require assessment.

Watch the distinction: A lower symptom score alone does not prove that treatment has met the patient's goal. Ask whether the change has improved the function they identified.

48. Checking apparent resistance

Before calling a treatment ineffective, reconstruct what the patient actually received. Recheck the diagnosis, including bipolar symptoms, substance use, medical contributors, and comorbidity. Ask about the prescribed dose, the doses taken, duration at that exposure, missed doses, adverse effects, and barriers such as cost or confusing instructions. Review interacting medicines and substances that may alter exposure. Continued stress, poor sleep, or an unsafe environment can sustain symptoms despite a useful treatment. Separate nonresponse despite an adequate trial from a trial limited by tolerability or adherence; these lead to different decisions. A practical response may involve managing nausea, simplifying administration, revising the treatment, or adding psychosocial support. Record the evidence for adequacy before using the label 'treatment resistant' or escalating to a more burdensome option.

Worked example: A patient says an antidepressant failed after two weeks. They were prescribed one dose daily but took only four doses in the past fourteen days because of nausea. Actual exposure was 4 ÷ 14, about 29% of prescribed days. That history cannot establish drug nonresponse. Assess the nausea, safety, diagnosis, and patient preference, then agree on a tolerable plan and a meaningful reassessment point.

Watch the distinction: Counting calendar time from the prescription date can overstate treatment exposure. A medication cannot be judged fairly when adverse effects have prevented most doses.

Reference: [4]

49. Response, remission and return of illness

Follow a patient's course using both symptoms and function. Response means meaningful improvement, which may still leave substantial illness; remission means symptoms and impairment have fallen to a minimal level for that patient. Relapse describes return of illness before recovery has been sustained, while recurrence refers to a new episode after recovery. These distinctions require a timeline, not one score at one visit. Ask about work, relationships, sleep, safety, and adverse effects as well as mood or anxiety. Residual symptoms can predict further difficulty and may reveal untreated comorbidity, ongoing stress, or inadequate treatment exposure. When improvement is incomplete, identify which problem remains and revise the plan with the patient. Avoid defining recovery solely by a numerical scale if the person still cannot perform important activities.

Worked example: After treatment, a patient's sleep improves and they report less sadness, but they still miss most workdays and withdraw from friends. This is partial improvement, not full remission, because impairment remains. The PMHNP checks concentration, medication effects, substance use, and workplace stress, then targets the remaining barriers. If symptoms later return after sustained recovery, that new period may be described as recurrence.

Watch the distinction: A single good week does not establish remission or a new episode boundary. Interpret symptoms against the longer course and whether daily functioning has recovered.

50. Pregnancy and postpartum planning

Perinatal planning weighs two kinds of exposure: effects of untreated illness and effects of treatment. Review illness severity, past relapse after stopping treatment, previous medication response, pregnancy stage, reproductive plans, lactation goals, and the patient's preferences. Discuss options with obstetric and other relevant clinicians so monitoring and responsibilities are clear. Avoid abrupt changes based only on a positive pregnancy test; the decision depends on the specific medicine and clinical history. After birth, distinguish common sleep disruption from a marked reduction in sleep accompanied by disorganization, mania, delusions, or hallucinations. Postpartum psychosis is an emergency because judgment and infant safety may be impaired. Arrange immediate assessment and ensure the patient and infant are safely supported while care is organized.

Worked example: A parent several days after birth has barely slept, speaks incoherently, and insists with fixed conviction that the infant faces a hidden threat. This combination of severe sleep loss, disorganization, and delusional belief requires emergency psychiatric and medical assessment. The PMHNP arranges safe supervision of the parent and infant, gathers collateral history, and coordinates urgent care rather than scheduling routine follow-up.

Watch the distinction: Treating every postpartum symptom as ordinary exhaustion can miss psychosis. A fixed false belief and disorganized behavior change the urgency even when sleep loss is present.

51. Care for older adults

In older adults, new psychiatric or cognitive symptoms often have several contributors. Compare the current state with baseline using a reliable informant, and ask whether the change was sudden or gradual and whether attention fluctuates. Review hearing and vision, pain, sleep, hydration, illnesses, and every prescription and nonprescription medicine. Sedating and anticholinergic effects can increase confusion and falls, especially when medicines are combined. Frailty and changes in organ function can alter drug exposure, so reassess after additions or dose changes. Adapt communication by reducing background noise, ensuring sensory aids work, and allowing time for answers. Evaluate function and gait as well as reported mood. A new fluctuating deficit calls for medical evaluation before a long-standing neurocognitive diagnosis is assigned.

Worked example: A patient with hearing loss seems inattentive two days after a sedating medicine was added. The PMHNP confirms that the hearing aid works, asks family about baseline, and checks alertness, falls, and the medication timeline. If attention varies during the visit, an acute drug effect or delirium becomes more plausible than steady cognitive decline. The next step is prompt medical and medication assessment.

Watch the distinction: Slow answers do not automatically indicate dementia. Poor hearing, sedation, and fluctuating attention can distort an interview and require different responses.

Reference: [4]

52. Integrated substance-use care

Psychiatric illness and substance use can worsen each other, so assess and treat both in one coordinated plan. Map substance use against mood, sleep, withdrawal, medication adherence, and functioning to avoid assuming one diagnosis explains everything. Address immediate overdose risk first, including access to an opioid reversal medication, safer-use education, and support after a nonfatal event. For opioid use disorder, consider evidence-based medication treatment such as buprenorphine or methadone through an appropriate service, alongside psychosocial and recovery support. Depression still needs assessment and follow-up; waiting for complete abstinence may leave a major source of impairment untreated. Coordinate clinicians so each knows the treatment plan, risk factors, and monitoring responsibilities. SAMHSA provides behavioral health and substance-use treatment resources. Use nonjudgmental language and set goals the patient can pursue now.

Worked example: A patient with depression returns after a nonfatal opioid overdose and says they want treatment but fear withdrawal. The PMHNP assesses current breathing, suicidality, and substance use; arranges overdose prevention and access to reversal medication; and connects the patient with an appropriate medication treatment pathway. Depression treatment continues alongside substance care, with shared follow-up and a plan for missed appointments.

Watch the distinction: Requiring abstinence before addressing depression can leave both conditions active. Immediate overdose prevention and longer-term psychiatric treatment can proceed together.

Reference: [3]

53. Transitions and physical health

A discharge plan must show what the patient will take, what will be monitored, and who will act on abnormal findings. Compare the preadmission list, inpatient orders, and intended home regimen to identify duplicate drugs, omissions, and changed doses. Explain the final list in language the patient can use. For antipsychotics, consider movement symptoms, sedation, weight and metabolic health, and other risks relevant to the chosen medicine; FDA drug information can help check product-specific safety details. Assign responsibility for laboratory review, physical measurements, refills, and follow-up rather than leaving these tasks unnamed. Communicate unresolved safety concerns and the action needed if they worsen. Ongoing care also addresses sleep, activity, tobacco use, and medical conditions that affect psychiatric outcomes. Confirm access to medicines and appointments before assuming that discharge instructions are workable.

Worked example: After an antipsychotic change, a discharge list contains both the old and new drugs although the old one was meant to stop. The PMHNP clarifies the final regimen, updates the list, and asks the patient to repeat it. The plan names the clinician who will check adverse effects and metabolic measures, confirms appointment access, and records what symptoms require earlier contact.

Watch the distinction: A scheduled appointment does not complete a transition. Duplicate prescriptions, unassigned monitoring, or unclear urgent instructions can undermine an otherwise sound treatment choice.

Reference: [4]

54. Trauma-informed interviewing

Trauma-responsive interviewing gives the patient predictability and a degree of control without abandoning necessary assessment. Explain why a sensitive question matters, ask permission to proceed, and offer choices such as taking a break or answering in general terms first. Use open questions and avoid repeated requests for graphic details that will not change safety assessment or treatment. Attend to signs of dissociation or escalating distress, slow the pace, and orient the person to the present when needed. Ask what helps them feel safe during care and record essential information accurately so later clinicians need not ask for the same account unnecessarily. Immediate danger, current symptoms, and functional effects still require assessment. The clinical aim is reliable information and a workable alliance, not a complete narrative of every event.

Worked example: Before asking about an assault, the PMHNP says the purpose is to understand current safety, intrusive memories, and avoidance. The patient chooses to describe the event briefly and pause when distressed. The clinician checks immediate danger and present symptoms, documents the limited history and the patient's preference, and agrees to revisit details only if they become necessary for treatment.

Watch the distinction: Avoiding all trauma questions can miss current danger and treatment needs. Asking for graphic detail without a clinical purpose can increase distress and reduce trust.

55. Cultural formulation

A cultural formulation asks what an experience means in the patient's own setting. Explore preferred language, family and community interpretations, spiritual practices, migration, discrimination, and how the person usually seeks help. Then assess whether the experience is expected in that context, whether it is distressing, and whether it disrupts functioning. Also look for disorganized thinking, fixed beliefs, impaired reality testing, mood episodes, or substance effects. Cultural context should refine clinical reasoning, not prevent assessment when danger or impairment is present. Ask the patient what explanation they find most convincing and what kind of help would be acceptable. Use collateral information with consent when it clarifies local norms or a change from the person's baseline. Document the patient's account separately from the clinician's interpretation.

Worked example: During mourning, a patient says they briefly hear a deceased relative's voice at a family ritual. They find it comforting, remain organized, and function as usual; relatives describe the experience as familiar in their tradition. Those facts do not by themselves indicate psychosis. The PMHNP still asks about distress, voices outside the ritual, mood symptoms, and changes in functioning before forming a conclusion.

Watch the distinction: An unfamiliar belief is not automatically a delusion. Cultural acceptance is also not a blanket explanation for severe distress, disorganization, or dangerous behavior.

56. Interpreters and accessible care

Accurate psychiatric assessment depends on the patient's own words and a communication channel they can trust. Use a qualified interpreter when the patient prefers another language, especially for risk, consent, trauma, and medication discussions. Speak directly to the patient, use short complete questions, and allow interpretation before moving on. A family member may have a separate role as support or collateral source, but interpreting sensitive disclosures can inhibit the patient and blur what was actually said. Arrange hearing, vision, literacy, or cognitive supports as needed. Check understanding by asking the patient to explain the agreed steps in their own words rather than asking only whether they understand. Record the interpreter's role, communication aids, and any limits that remain. Reassess risk if a language barrier made the first account uncertain. These communication skills also support psychiatric mental health nursing, where accurate handoffs depend on the patient's account.

Worked example: A patient prefers another language and a relative offers to interpret a discussion of self-harm. The PMHNP arranges a qualified interpreter and asks the patient directly about intent, means, and supports. After making a safety plan, the patient explains through the interpreter whom they will call and where the written plan is kept. The relative can assist with agreed support if the patient consents.

Watch the distinction: A nod or brief 'yes' does not establish understanding. Sensitive risk answers may change when the patient can speak privately through a qualified interpreter.

57. Decision-making capacity

Capacity concerns a particular decision at a particular time. Assess whether the patient can understand relevant information, appreciate how it applies to their own situation, compare options with a reasoned explanation, and communicate a choice. A choice that differs from the clinician's recommendation is not itself evidence of incapacity. Conversely, repeating facts accurately does not show appreciation if the patient cannot connect an immediate risk to themselves. Explore whether delirium, intoxication, psychosis, severe mood symptoms, pain, or a communication barrier is affecting the assessment, and address reversible problems where possible. Document the decision, information presented, the patient's responses, and why each ability is or is not present. Clinical capacity assessment is distinct from a legal determination of competence, and emergency action still depends on the applicable facts and rules.

Worked example: A patient refuses admission and accurately repeats that clinicians are concerned about self-harm. Asked how that risk applies personally, they insist an observed recent attempt 'could not have happened' despite understanding the words. The PMHNP probes appreciation, checks for intoxication or psychosis, and documents the responses. A coherent refusal alone does not settle capacity for this admission decision.

Watch the distinction: Disagreement with a recommended treatment does not prove incapacity. The assessment must test the four abilities for the actual decision and account for communication barriers.

58. Consent, assent and confidentiality

Consent and confidentiality questions must be answered from the patient's circumstances and the jurisdictional facts given. Identify who has authority to consent for the service, whether an adolescent may consent independently, and whether assent should be sought even when another person gives legal consent. Explain the proposed care, material risks and alternatives, and the limits of privacy in language the patient can understand. Then apply any stated exceptions for mandatory reporting, imminent harm, or required parental involvement. Share only information necessary for the permitted purpose, and tell the patient about a required disclosure when safe and appropriate. Document the source of consent, the patient's participation, and the reason for any disclosure. Because rules differ across places and services, an age alone cannot establish the correct legal answer.

Worked example: A hypothetical case says a 16-year-old may consent independently to outpatient mental health care, records are confidential from parents, and imminent self-harm requires protective disclosure. The adolescent requests privacy and denies current self-harm thoughts. The PMHNP can proceed with the adolescent's consent and explain those privacy limits. If imminent danger later emerges, the stated exception changes what must be disclosed.

Watch the distinction: Do not assume that every minor's parent must receive all psychiatric information. Equally, promising absolute confidentiality ignores stated safety and reporting exceptions.

59. Boundaries, records and consultation

Therapeutic boundaries protect clinical judgment and the patient's freedom to speak without conflicting obligations. A personal financial arrangement can create pressure, dependency, or divided interests, even when the patient proposes it. Decline clearly and respectfully, then return to the clinical concern that prompted the request. Document relevant facts, assessment, rationale, and follow-up without speculative labels or unnecessary private detail. Consultation is useful when risk, diagnosis, ethics, or treatment needs exceed the PMHNP's competence; referral should include a safe handoff rather than an unexplained discharge. Preserve continuity while defining each clinician's role. Records should let another professional understand what was observed, what alternatives were considered, and why the chosen action fits the patient's situation. Boundaries also apply to messages, gifts, social contact, and digital interactions.

Worked example: A patient being assessed for complex dissociative symptoms asks the PMHNP to invest in a personal business. The clinician declines the arrangement, asks whether financial stress is affecting symptoms, and records the clinical discussion and boundary. Because the presentation exceeds the clinician's experience, they seek consultation and arrange an appropriate referral while maintaining necessary interim care.

Watch the distinction: A patient initiating a financial relationship does not remove the boundary problem. The clinician remains responsible for preserving independent judgment and documenting a safe care plan.

60. Telehealth safety

Remote psychiatric care begins with practical safety facts. Verify the patient's current physical location at each encounter, a callback number, whether they can speak privately, and how local emergency help can reach them. Clarify who is nearby, with the patient's consent, and what to do if the connection fails. These details matter because an emergency response must be sent to the patient's location, which may differ from the clinician's. Adapt the interview for limited visual or audio cues and check understanding of medication and safety instructions. If imminent self-harm emerges, maintain contact while activating the agreed emergency pathway and arranging local assistance. Document the location, risk findings, actions, and handoff. Clinical and legal requirements depend on the jurisdiction in which the patient is located, using only rules specified in a case.

Worked example: A patient joins from a friend's apartment, then reports imminent self-harm. The PMHNP obtains the exact address and callback number, asks about immediate access to means, and keeps the connection open. Using the local emergency contact identified for that location, the clinician arranges urgent help and a handoff. The unfamiliar setting makes location verification essential before dispatch.

Watch the distinction: A home address on file may be useless during a remote crisis. Confirm where the patient is now and how to reconnect before relying on an emergency plan.